Standout Papers

C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration 2020 2026 2022 2024282
  1. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration (2020)
    Glenn J. Jaffe, Keith Westby et al. Ophthalmology
  2. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial (2023)
    Sunil Patel, David R. Lally et al. Eye

Immediate Impact

61 standout
Sub-graph 1 of 22

Citing Papers

Recent Advances in Food Safety Detection: Split Aptamer-Based Biosensors Development and Potential Applications
2025 Standout
Glucagon-like Peptide-1 Receptor Agonist Impact on Chronic Ocular Disease Including Age-Related Macular Degeneration
2025 Standout
3 intermediate papers

Works of Keith Westby being referenced

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
2023 Standout
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
2020 Standout

Author Peers

Author Last Decade Papers Cites
Keith Westby 436 242 288 6 592
Tsunehiko Yoshida 346 367 162 11 663
Harvey Masonson 473 231 312 6 617
Gordon Byrnes 378 165 163 11 524
Yumiko Saishin 430 325 245 10 622
Annette M. Aoki 224 226 265 9 549
Katharina E. Schmid‐Kubista 328 172 289 14 536
Sankaranarayanan Kaliappan 429 180 194 8 548
Manlin Jin 303 369 206 12 608
Hajime Inomata 420 294 193 11 576
J. M. Bradley 534 198 214 6 674

All Works

Loading papers...

Rankless by CCL
2026